InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Biotechnology and patentability: navigating unchartered waters in Australia and the US


The debate over the patentability of isolated DNA has raged around the world. Tania Obranovich compares the two Myriad decisions from the highest courts in Australia and the US and explains how the Australian decision has called into question what had long been thought of as a fundamental pillar of Australian patent law

Myriad's BRCA patents, which claim both breast cancer diagnostic methods and the isolated BRCA DNA molecules, have courted significant controversy both in Australia and the US in recent years. Extensive judicial consideration in relation to the patent eligibility of isolated...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Jaguar Land Rover to trademark Defender design to see off rivals https://t.co/9XxH3FwZID via @FT

Sep 22 2017 08:55 ·  reply ·  retweet ·  favourite
ManagingIP profile

@patentassertion @Mathys_Squire Would you be interested in writing a follow up looking at trends in other jurisdictions, eg DE, FR, IT & NL?

Sep 21 2017 04:25 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @MarquesIP: At #marques17 Dimitris Botis of @EU_IPO & Simon Malynicz of @3NewSquare discuss the EUTM changes coming on October 1 #EUIPO0…

Sep 21 2017 08:53 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

September 2017

How UK IP firms hope to survive Brexit

The UK’s departure from the EU threatens to disrupt IP practice in the country – and patent and trade mark firms are already taking steps to mitigate the potential damage. James Nurton reports



Most read articles

Supplements